Back to results

CompletedPhase 3

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

A.Z. St. Jan

Bruges, Belgium

+23 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 1999-06
Enrollment: 115 participants
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Purpose: supportive care

Locations (24)

A.Z. St. JanBruges, Belgium
Institut Jules BordetBrussels, Belgium
Hopital Universitaire ErasmeBrussels, Belgium
U.Z. GasthuisbergLeuven, Belgium
Clinique Universitaire De Mont-GodinneMont-Godinne Yvoir, Belgium
University Hospital - OlomoucOlomouc, Czechia
CHU de CaenCaen, France
Centre Hospitalier Universitaire Henri MondorCréteil, France
Hopital Saint-LouisParis, France
Universitaetsklinikum ChariteBerlin, Germany
Virchow Klinikum Humboldt Universitaet BerlinBerlin, Germany
Athens University-Laikon General HospitalAthens, Greece
Hippokration HospitalThessaloniki, Greece
Szent Laszlo KorhazBudapest, Hungary
Hadassah University HospitalJerusalem, Israel
Istituto Nazionale per la Ricerca sul CancroGenoa (Genova), Italy
University Medical Center NijmegenNijmegen, Netherlands
Hospital De Santo Antonio Dos CapuchosLisbon (Lisboa), Portugal
National Cancer Institute - BratislavaBratislava, Slovakia
Hospital de la Santa Cruz I Sant PauBarcelona, Spain
Hospital Central de AsturiasOviedo, Spain
Huddinge University HospitalStockholm, Sweden
Section of Infectious DiseasesAnkara, Turkey (Türkiye)
Tawam HospitalAbu Dhabi, United Arab Emirates

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients — TrialFind